Paper Details

  1. Home
  2. Paper Details

[Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab].

Author: Bénéton-BenhardN, DelaitreL, DenisD, MaillardH, Martins-HéricherJ, ProphetteB, TruchotE

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Pembrolizumab, an anti-PD1 antibody, may be effective as a second-line therapy for advanced squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). This case report describes a patient with advanced SCC and BCC who experienced regression under pembrolizumab treatment.
Paper Details　
Original Abstract of the Article :
The recommended treatments for advanced squamous cell carcinoma (SCC) (chemotherapy, radiotherapy, anti-EGFR) and advanced basal cell carcinoma (BCC) (vismodegib and sonidegib) have many side effects. Nivolumab (anti-PD1 antibody) may be used as second-line therapy in SCC of the head and neck. We re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.annder.2019.10.031

データ提供：米国国立医学図書館（NLM）

Pembrolizumab: A Glimpse of Hope in the Desert of Skin Cancer

Skin cancer is a serious health concern, much like a desert that can be unforgiving. This case report explores the potential of pembrolizumab, an immunotherapy drug, for treating advanced basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The authors describe the case of a patient with advanced SCC and BCC who experienced regression of their tumors after receiving pembrolizumab.

A New Oasis in Skin Cancer Treatment

This case report offers a glimpse of hope in the desert of skin cancer treatment. The regression of advanced SCC and BCC in this patient suggests that pembrolizumab may have a promising role in treating these challenging cancers.

Navigating the Desert of Skin Cancer

For those facing skin cancer, this case report highlights the importance of staying informed about new treatment options. It reminds us that research is constantly evolving, and new therapies are emerging that offer potential hope for patients.

Dr.Camel's Conclusion

This case report underscores the potential of pembrolizumab as a promising treatment option for advanced basal cell carcinoma and squamous cell carcinoma. While further research is needed, it offers a glimmer of hope in the desert of skin cancer treatment, reminding us that new therapies are constantly being explored to combat this challenging disease.

Date :
  1. Date Completed 2020-12-30
  2. Date Revised 2020-12-30
Further Info :

Pubmed ID

31879092

DOI: Digital Object Identifier

10.1016/j.annder.2019.10.031

Related Literature

Article Analysis
・Side Effects of sonidegib
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.